Home
PB Ratio of Par Drugs & Chemicals Ltd
Par Drugs & Chemicals Ltd
NSE: PAR
PB Ratio
Key Highlights
- The latest PB Ratio of Par Drugs & Chemicals Ltd is 1.2.
- The PB ratio of the Par Drugs & Chemicals Ltd is below 1.5 which indicates that the stock is fairly valued.
- The P/B Ratio of Par Drugs & Chemicals Ltd changed from 0.5 on March 2020 to 1.1 on March 2025 . This represents a CAGR of 14.04% over 6 years.
Historical P/B Ratio of Par Drugs & Chemicals Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Par Drugs & Chemicals Ltd
Company Fundamentals for Par Drugs & Chemicals Ltd
Market Price of Par Drugs & Chemicals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 26 Dec 2025 | 104.03 |
| 24 Dec 2025 | 107.47 |
| 23 Dec 2025 | 105 |
| 22 Dec 2025 | 106.13 |
| 19 Dec 2025 | 110.81 |
| 18 Dec 2025 | 105.11 |
| 17 Dec 2025 | 99.13 |
| 16 Dec 2025 | 100.42 |
| 15 Dec 2025 | 101.48 |
| 12 Dec 2025 | 92.05 |
SWOT Analysis Of Par Drugs & Chemicals Ltd
BlinkX Score for Par Drugs & Chemicals Ltd
Asset Value vs Market Value of Par Drugs & Chemicals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
| Company | PB | Market Cap |
|---|
| Par Drugs & Chemicals Ltd | 1.2 | 128.01 |
| Sun Pharmaceutical Industries Ltd | 99.2 | 412494 |
| Divis Laboratories Ltd | 578.3 | 170514 |
| Torrent Pharmaceuticals Ltd | 249.8 | 129044 |
| Cipla Ltd | 411.6 | 121574 |
| Company | |
|---|---|
| Par Drugs & Chemicals Ltd | 1.2 |
| Sun Pharmaceutical Industries Ltd | 99.2 |
| Divis Laboratories Ltd | 578.3 |
| Torrent Pharmaceuticals Ltd | 249.8 |
| Cipla Ltd | 411.6 |
Key Valuation Metric of Par Drugs & Chemicals Ltd
₹
₹
X
Historical Market Cap of Par Drugs & Chemicals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Par Drugs & Chemicals Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Par Drugs & Chemicals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Par Drugs & Chemicals Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Par Drugs & Chemicals Ltd News Hub
Par Drugs & Chemicals AGM scheduled
Par Drugs & Chemicals announced that the 25th Annual General Meeting (AGM) of the company will be he
Read more
19 Aug 24
Par Drugs & Chemicals to declare Quarterly Result
Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 17 August 2024
Read more
10 Aug 24
Par Drugs & Chemicals standalone net profit rises 2.43% in the June 2024 quarter
Net profit of Par Drugs & Chemicals rose 2.43% to Rs 2.53 crore in the quarter ended June 2024 as ag
Read more
05 Aug 24
Par Drugs & Chemicals to declare Quarterly Result
Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 22 October 202
Read more
14 Oct 24
